Estrogen-dependent inherited angioedema.

[1]  M. Whitehead,et al.  Effects of oestrogen‐only and oestrogen–progestogen replacement therapy upon circulating angiotensin I‐converting enzyme activity in postmenopausal women , 2003, Clinical endocrinology.

[2]  M. Kurabayashi,et al.  Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[3]  A. Toutain,et al.  Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. , 2001, The Journal of allergy and clinical immunology.

[4]  K. Binkley,et al.  Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.

[5]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[6]  A. Davis.  C1 Inhibitor Gene and Hereditary Angioedema , 1998 .

[7]  J. Volanakis.  The human complement system in health and disease , 1998 .

[8]  J. Chao,et al.  Regulation of bradykinin B2‐receptor expression by oestrogen , 1997, British journal of pharmacology.

[9]  F. Rosen,et al.  Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.

[10]  A. Sacchi,et al.  Molecular basis of estrogen regulation of Hageman factor XII gene expression. , 1995, Endocrinology.

[11]  N. Hoem,et al.  Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII. , 1994, Thrombosis research.

[12]  S. Tarlo,et al.  C1 esterase inhibitor in pregnancy. , 1992, The Journal of allergy and clinical immunology.

[13]  S. Leodolter,et al.  C1-Esterase Inhibitor in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia , 1991, Thrombosis and Haemostasis.

[14]  A. Falus,et al.  Hormonal regulation of complement biosynthesis in human cell lines--I. Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. , 1990, Molecular immunology.

[15]  K. Whaley,et al.  Monocyte C1‐inhibitor synthesis in patients with C1‐inhibitor deficiency , 1989, European journal of clinical investigation.

[16]  F. Rosen,et al.  Angioedema induced by a peptide derived from complement component C2 , 1988, The Journal of experimental medicine.

[17]  S. Williams,et al.  Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII. , 1988, The Journal of laboratory and clinical medicine.

[18]  J. Jespersen,et al.  Increased Euglobulin Fibrinolytic Potential in Women on Oral Contraceptives Low in Oestrogen – Levels of Extrinsic and Intrinsic Plasminogen Activators, Prekallikrein, Factor XII, and C1-Inactivator , 1985, Thrombosis and Haemostasis.

[19]  Robert B Sim,et al.  The effect of danazol on the production of C1 inhibitor in the guinea pig. , 1984, Complement.

[20]  R. Colman,et al.  Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. , 1983, The New England journal of medicine.

[21]  D. Ogston,et al.  C1 inactivator level in pregnancy. , 1981, Thrombosis research.

[22]  O. Ratnoff,et al.  Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.

[23]  M. Cicardi,et al.  Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. , 1980, Annals of allergy.

[24]  J. Gelfand,et al.  Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. , 1980, The New England journal of medicine.

[25]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[26]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[27]  A. Sheffer,et al.  Tranexamic acid therapy in hereditary angioneurotic edema. , 1972, The New England journal of medicine.

[28]  F. Rosen,et al.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.

[29]  F. Rosen,et al.  Hereditary angioneurotic edema: a clinical survey. , 1966, Pediatrics.

[30]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[31]  W. Spaulding.  METHYLTESTOSTERONE THERAPY FOR HEREDITARY EPISODIC EDEMA (HEREDITARY ANGIONEUROTIC EDEMA) , 1960 .